Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial

Patricia Teran-Wodzinski, Douglas Haladay, Tuan Vu, Ming Ji, Jillian Coury, Alana Adams, Lauren Schwab, Constance Visovsky, Patricia Teran-Wodzinski, Douglas Haladay, Tuan Vu, Ming Ji, Jillian Coury, Alana Adams, Lauren Schwab, Constance Visovsky

Abstract

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and understudied consequence of taxane chemotherapy for breast cancer treatment. CIPN symptoms include numbness combined with tingling sensations, persistent shooting, stabbing, or burning pain even in the absence of painful stimuli, lower extremity muscle weakness, and impaired balance. CIPN symptoms often persist for a long time after completion of chemotherapy, causing significant loss of functional abilities and increased risk of falls. Persistent CIPN caused by taxanes represents a therapeutic challenge due to the limited treatment options. Resistance exercise has shown promising results; however, the effect of exercise on CIPN remains understudied. This study aims to assess the effects of exercise on gait, balance, and lower extremity muscle strength after a 16-week home-based exercise program compared to an educational attention control condition.

Methods: A sample of 312 women who completed taxane-based chemotherapy for breast cancer and have symptomatic neuropathy is recruited from a community-dwelling sample. Participants are randomized to either a 16-week Home-Based Physical Activity Intervention or an Educational Attention control group. The home-based intervention protocol consists of targeted lower extremity stretches, followed by 10 min each of gait/balance and 10 min of resistive training accessed by hyperlink or DVD. An Exercise Diary records quantitative exercise data. The gait assessment includes temporospatial parameters and lower extremity joint angles using APDM motion sensors. Participants' balance is assessed using the Sensory Organization Test (SOT) performed using a NeuroCom Balance Master. Isometric strength of hip, knee, and ankle flexor and extensor muscles is assessed using an isokinetic dynamometer, Biodex BX Advantage. In addition, we assess neuropathy symptoms using the FACT-Taxane Additional Concerns Subscale and nerve conduction velocity of the sural and peroneal nerve action potentials. Outcomes are assessed at baseline (prior to randomization) and 16 weeks.

Discussion: There are currently no evidence-based interventions that address the functional declines associated with CIPN. If successful, this program is simple and easy to implement in the standard of care for individuals with CIPN. Gait and balance training have the potential to reduce physical dysfunction associated with CIPN and reduce the burden of disease in cancer survivors.

Trial registration: ClinicalTrials.gov NCT04621721 . Registered on August 3, 2020. ClincialTrials.gov is a primary registry of the World Health Organization International Clinical Trials Registry Platform (WHO ICTEP) network and includes all items from the WHO Trial Registration data set in Trial registration.

Keywords: Breast cancer; Chemotherapy-induced peripheral neuropathy; Therapeutic exercise.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Participant flow diagram
Fig. 2
Fig. 2
Schedule of enrolment, interventions, and assessments
Fig. 3
Fig. 3
APDM Opal Sensors Placement. IMUs (inertial measurement units), LC (lateral condyle), TT (tibial tuberosity), TAT (tibialis anterior tendon), SL (shoe length)

References

    1. Rivera E, Cianfrocca M. Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer. Cancer Chemother Pharmacol. 2015;75(4):659–670. doi: 10.1007/s00280-014-2607-5.
    1. Bachegowda LS, Makower DF, Sparano JA. Taxanes: impact on breast cancer therapy. Anticancer Drugs. 2014;25(5):512–521. doi: 10.1097/CAD.0000000000000090.
    1. Bennett GJ, Doyle T, Salvemini D. Mitotoxicity in distal symmetrical sensory peripheral neuropathies. Nat Rev Neurol. 2014;10(6):326–336. doi: 10.1038/nrneurol.2014.77.
    1. Kolb NA, Smith AG, Singleton JR, Beck SL, Stoddard GJ, Brown S, Mooney K. The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling. JAMA Neurol. 2016;73(7):860–866. doi: 10.1001/jamaneurol.2016.0383.
    1. Eckhoff L, Knoop A, Jensen MB, Ewertz M. Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors. Eur J Cancer. 2015;51(3):292–300. doi: 10.1016/j.ejca.2014.11.024.
    1. Visovsky C, Daly BJ. Clinical evaluation and patterns of chemotherapy-induced peripheral neuropathy. J Am Acad Nurse Pract. 2004;16(8):353–359. doi: 10.1111/j.1745-7599.2004.tb00458.x.
    1. Manor B, Li L. Characteristics of functional gait among people with and without peripheral neuropathy. Gait Posture. 2009;30(2):253–256. doi: 10.1016/j.gaitpost.2009.04.011.
    1. Brill PA, Macera CA, Davis DR, Blair SN, Gordon N. Muscular strength and physical function. Med Sci Sports Exerc. 2000;32(2):412–416. doi: 10.1097/00005768-200002000-00023.
    1. Park JS, Kim S, Hoke A. An exercise regimen prevents development paclitaxel induced peripheral neuropathy in a mouse model. J Peripher Nerv Syst. 2015;20(1):7–14. doi: 10.1111/jns.12109.
    1. Park J-S, Höke A. Treadmill exercise induced functional recovery after peripheral nerve repair is associated with increased levels of neurotrophic factors. PLoS One. 2014;9(3):e90245. doi: 10.1371/journal.pone.0090245.
    1. Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fung C, Janelsins MC, Asare M, Lin PJ, Reddy PS, Giguere J, Berenberg J, Kesler SR, Mustian KM. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer. 2018;26(4):1019–1028. doi: 10.1007/s00520-017-4013-0.
    1. Bland KA, Kirkham AA, Bovard J, Shenkier T, Zucker D, McKenzie DC, Davis MK, Gelmon KA, Campbell KL. Effect of exercise on taxane chemotherapy-induced peripheral neuropathy in women with breast cancer: a randomized controlled trial. Clin Breast Cancer. 2019;19(6):411–422. doi: 10.1016/j.clbc.2019.05.013.
    1. Kleckner IR, Kamen C, Cole C, Fung C, Heckler CE, Guido JJ, Culakova E, Onitilo AA, Conlin A, Kuebler JP, Mohile S, Janelsins M, Mustian KM. Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial. Support Care Cancer. 2019;27(12):4615–4625. doi: 10.1007/s00520-019-04772-7.
    1. Visovsky C, Bovaird JA, Tofthagen C, Rice J. Heading off peripheral neuropathy with exercise: the hope study. Nurs Health. 2014;2(6):115–121. doi: 10.13189/nh.2014.020602.
    1. Streckmann F, Zopf EM, Lehmann HC, May K, Rizza J, Zimmer P, Gollhofer A, Bloch W, Baumann FT. Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med. 2014;44(9):1289–1304. doi: 10.1007/s40279-014-0207-5.
    1. Chan AW, Tetzlaff JM, Gøtzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346(jan08 15):e7586. doi: 10.1136/bmj.e7586.
    1. Gawronska A, Pajor A, Zamyslowska-Szmytke E, Rosiak O, Jozefowicz-Korczynska M. Usefulness of mobile devices in the diagnosis and rehabilitation of patients with dizziness and balance disorders: a state of the art review. Clin Interv Aging. 2020;15:2397–2406. doi: 10.2147/CIA.S289861.
    1. Mancini M, Horak FB. Potential of APDM mobility lab for the monitoring of the progression of Parkinson's disease. Expert Rev Med Devices. 2016;13(5):455–462. doi: 10.1586/17434440.2016.1153421.
    1. Ford-Smith CD, Wyman JF, Elswick RK, Jr, Fernandez T, Newton RA. Test-retest reliability of the sensory organization test in noninstitutionalized older adults. Arch Phys Med Rehabil. 1995;76(1):77–81. doi: 10.1016/S0003-9993(95)80047-6.
    1. Harro CC, Garascia C. Reliability and validity of computerized force platform measures of balance function in healthy older adults. J Geriatr Phys Ther. 2019;42(3):E57–e66. doi: 10.1519/JPT.0000000000000175.
    1. Harro CC, Marquis A, Piper N, Burdis C. Reliability and validity of force platform measures of balance impairment in individuals with Parkinson disease. Phys Ther. 2016;96(12):1955–1964. doi: 10.2522/ptj.20160099.
    1. Kierkegaard S, Mechlenburg I, Lund B, Søballe K, Dalgas U. Impaired hip muscle strength in patients with femoroacetabular impingement syndrome. J Sci Med Sport. 2017;20(12):1062–1067. doi: 10.1016/j.jsams.2017.05.008.
    1. Nomura T, Kawae T, Kataoka H, Ikeda Y. Assessment of lower extremity muscle mass, muscle strength, and exercise therapy in elderly patients with diabetes mellitus. Environ Health Prev Med. 2018;23(1):20. doi: 10.1186/s12199-018-0710-7.
    1. Rice DA, Mannion J, Lewis GN, McNair PJ, Fort L. Experimental knee pain impairs joint torque and rate of force development in isometric and isokinetic muscle activation. Eur J Appl Physiol. 2019;119(9):2065–2073. doi: 10.1007/s00421-019-04195-6.
    1. Andersen H. Reliability of isokinetic measurements of ankle dorsal and plantar flexors in normal subjects and in patients with peripheral neuropathy. Arch Phys Med Rehabil. 1996;77(3):265–268. doi: 10.1016/S0003-9993(96)90109-4.
    1. Cella D, Peterman A, Hudgens S, Webster K, Socinski MA. Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane) Cancer. 2003;98(4):822–831. doi: 10.1002/cncr.11578.
    1. Sohn EH, Lee JS, Jung MS, Kim JR. A prospective study of taxane-induced neuropathy with breast cancer: proper assessment tool for taxane-induced neuropathy. South Asian J Cancer. 2021;10(2):58–63. doi: 10.1055/s-0041-1731100.
    1. Muthén L, Muthén B. Mplus user’s guide. 4. Los Angeles: Muthen & Muthen; 1998.
    1. Muthén LK, Muthén BO. How to use a Monte Carlo study to decide on sample size and determine power. Struct Equ Modeling. 2002;9(4):599–620. doi: 10.1207/S15328007SEM0904_8.
    1. Conn VS, Hafdahl AR, Porock DC, McDaniel R, Nielsen PJ. A meta-analysis of exercise interventions among people treated for cancer. Support Care Cancer. 2006;14(7):699–712. doi: 10.1007/s00520-005-0905-5.
    1. Balducci S, Iacobellis G, Parisi L, di Biase N, Calandriello E, Leonetti F, Fallucca F. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications. 2006;20(4):216–223. doi: 10.1016/j.jdiacomp.2005.07.005.
    1. Fisher MA, Langbein WE, Collins EG, Williams K, Corzine L. Physiological improvement with moderate exercise in type II diabetic neuropathy. Electromyogr Clin Neurophysiol. 2007;47(1):23–28.
    1. Ruhland JL, Shields RK. The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies. Phys Ther. 1997;77(10):1026–1039. doi: 10.1093/ptj/77.10.1026.
    1. Graham RC, Hughes RA, White CM. A prospective study of physiotherapist prescribed community based exercise in inflammatory peripheral neuropathy. J Neurol. 2007;254(2):228–235. doi: 10.1007/s00415-006-0335-4.
    1. Teran-Wodzinski P, Adams A, Haladay DE, et al. Development of an innovative research protocol to assess gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN). Gait and Clinical Movement Analysis Society Annual Conference; June 8-9, 2021, 2021; Online.
    1. Maffiuletti NA, Bizzini M, Widler K, Munzinger U. Asymmetry in quadriceps rate of force development as a functional outcome measure in TKA. Clin Orthop Relat Res. 2010;468(1):191–198. doi: 10.1007/s11999-009-0978-4.
    1. Thorstensson A, Grimby G, Karlsson J. Force-velocity relations and fiber composition in human knee extensor muscles. J Appl Physiol. 1976;40(1):12–16. doi: 10.1152/jappl.1976.40.1.12.
    1. Maganaris CN. Force-length characteristics of in vivo human skeletal muscle. Acta Physiol Scand. 2001;172(4):279–285. doi: 10.1046/j.1365-201x.2001.00799.x.
    1. Van Driessche S, Van Roie E, Vanwanseele B, Delecluse C. Test-retest reliability of knee extensor rate of velocity and power development in older adults using the isotonic mode on a Biodex System 3 dynamometer. PLoS One. 2018;13(5):e0196838. doi: 10.1371/journal.pone.0196838.
    1. Krantz MM, Åström M, Drake AM. Strength and fatigue measurements of the hip flexor and hip extensor muscles: test-retest reliability and limb dominance effect. Int J Sports Phys Ther. 2020;15(6):967–976. doi: 10.26603/ijspt20200967.
    1. Hartmann A, Knols R, Murer K, de Bruin ED. Reproducibility of an isokinetic strength-testing protocol of the knee and ankle in older adults. Gerontology. 2009;55(3):259–268. doi: 10.1159/000172832.
    1. Allison PD. Missing Data. SAGE Research Methods. Quantitative Applications in the Social Sciences. Thousand Oaks: SAGE Publications, Inc.; 2002. 10.4135/9781412985079. 19 Apr 2022.
    1. Bovaird JA. Multilevel structural equation models for contextual factors. In: Little TD, Bovaird JA, Card NA, editors. Modeling contextual effects in longitudinal studies. Mahwah: Erlbaum; 2007. pp. 149–182.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit